Aniket Pharma Private Limited

Aniket Pharma Private Limited - chemicals and materials in Kalol, Gujarat, India. FY 2026 financials & compliance.
CIN U24111GJ2006PTC048288 Incorporated 19 May 2006 ROC Ahmedabad HQ Kalol, Gujarat, India
Active Private Limited Company chemicals and materials
Data last updated
Revenue · FY 2022
₹46,907
▲ 17872% YoY
Net loss · FY 2022
₹21.73 Lakh
Latest filing
EBITDA · FY 2022
-₹21.73 Lakh
Latest filing
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Satisfied charges
₹1.75 Cr
No open charges
Company age
20 yrs
Est. 2006
Directors on board
4
As per MCA filings

About Aniket Pharma Private Limited

Data last updated:

Aniket Pharma Private Limited is a private limited company based in Kalol, Gujarat, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 19 May 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24111GJ2006PTC048288.

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Parimal Bharatkumar Patel and Vinaykumar Mohanlal Patel.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 9 – 10 – 11 Milan Industrial Estate Besides Bharat Petroleum Post. Santej Vadsar Road, Kalol, Gujarat, India – 382721.

As per the financials filed for FY 2022, the company reported a revenue of ₹46,907, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹21.73 Lakh and EBITDA of -₹21.73 Lakh. Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.

As per MCA filings, the company has satisfied charges of ₹1.75 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24111GJ2006PTC048288
Registration Number 048288
Incorporation Date 19 May 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant

Contact details

Aniket Pharma Private Limited's registered office is in Kalol, Gujarat. Its e-mail address is in the company report.

  • Email
  • Registered Address
    9 – 10 – 11 Milan Industrial Estate Besides Bharat Petroleum Post. Santej Vadsar Road, Kalol, Gujarat, India – 382721
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Aniket Pharma Private Limited, buy the company report.

Comprehensive company report
Aniket Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Aniket Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Aniket Pharma Private Limited, buy the company report.

Financials of Aniket Pharma Private Limited

FY 2022 filings available

Aniket Pharma Private Limited reported revenue of ₹46,907 (up 17872% YoY) for FY 2022.

Revenue · FY 2022
₹46,907 ▲ 17872%
Net loss · FY 2022
₹21.73 Lakh
EBITDA · FY 2022
-₹21.73 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 6%
5 years · compounded
▲ 8%
EBITDA CAGR growth
3 years · compounded
▼ 429%
5 years · compounded
▼ 203%

Revenue has grown at a compounded annual rate (CAGR) of 8% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹46,907
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹21.73 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹21.73 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aniket Pharma Private Limited, buy the company report.

Board of directors of Aniket Pharma Private Limited

Aniket Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Parimal Bharatkumar PatelDirector02 Feb 200917 Years 9 MonthsCurrent
Vinaykumar Mohanlal PatelDirector19 May 200620 Years 5 MonthsCurrent
Patel Anilkumar SankabhaiDirector19 May 200620 Years 5 MonthsCurrent
Narsinhbhai Dhanjibhai PatelDirector19 May 200620 Years 5 MonthsCurrent

Auditor

Aniket Pharma Private Limited is audited by DANG & ASSOCIATES LLP for the financial year 2020.

Auditor firmFinancial yearFirm registration number
DANG & ASSOCIATES LLPFY 2020W100148

Shareholding

The shareholding of Aniket Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aniket Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1.75 Cr
Breakdown by lending institutions
Bank of Baroda₹1.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Nov 200710076069Bank of Baroda₹1.75 CrSatisfied

To see the full charge records of Aniket Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aniket Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Aniket Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Aniket Pharma Private Limited has 9 board changes on record since 2006: 4 appointments and 5 cessations. The latest: Hasmukhbhai Ambarambhai Patel ceased to be Director on 01 Jun 2019.

AGM
Aniket Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Aniket Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad.
Ceased
Hasmukhbhai Ambarambhai Patel ceased to be Director.
Ceased
Rajesh Laljibhai Patel ceased to be Director.
Ceased
Rajesh Mangalbhai Patel ceased to be Director.
Ceased
Riteshbhai Gangabhai Prajapati ceased to be Director.
Ceased
Vinod Parasottamdas Patel ceased to be Director.
Charges
A charge registered on 02 Nov 2007 via Charge ID 10076069 with Bank Of Baroda was fully satisfied on 27 Jan 2015.
Appointed
Parimal Bharatkumar Patel was appointed as Director.
Charges
A charge with Bank Of Baroda amounted to Rs. 175.00 Lakh with Charge ID 10076069 was registered on 02 Nov 2007.
Appointed
Narsinhbhai Dhanjibhai Patel was appointed as Director.
Appointed
Patel Anilkumar Sankabhai was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Aniket Pharma is an active private limited company based in Kalol, Gujarat, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 19 May 2006 (20+ years old) and is registered under CIN U24111GJ2006PTC048288.

Aniket Pharma has 4 current directors:

The latest financial statements of Aniket Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Aniket Pharma is U24111GJ2006PTC048288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aniket Pharma was incorporated on 19 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Hasmukhbhai Ambarambhai Patel ceased to be Director on 01 Jun 2019. Rajesh Laljibhai Patel ceased to be Director on 01 Jun 2019. Rajesh Mangalbhai Patel ceased to be Director on 01 Jun 2019. Aniket Pharma has 9 board changes on record in total.

The registered office of Aniket Pharma is at 9 – 10 – 11 Milan Industrial Estate Besides Bharat Petroleum Post. Santej Vadsar Road, Kalol, Gujarat, India – 382721.

Aniket Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.

Aniket Pharma has no open charges and satisfied charges of ₹1.75 Cr as per latest MCA filings.

The compliance status of Aniket Pharma is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.